Janssen pharma collaborates with Beth Israel Deaconess Medical Center for COVID-19 Vaccine Development Medical Dialogues Bureau14 March 2020 9:30 AM ISTJanssen's vaccine program will use the Janssen AdVac® and PER.C6® technologies that provide the ability to rapidly upscale production of an optimal...